DK1648925T3 - Bicyklisk peptid-billeddannende midler - Google Patents
Bicyklisk peptid-billeddannende midlerInfo
- Publication number
- DK1648925T3 DK1648925T3 DK04743485T DK04743485T DK1648925T3 DK 1648925 T3 DK1648925 T3 DK 1648925T3 DK 04743485 T DK04743485 T DK 04743485T DK 04743485 T DK04743485 T DK 04743485T DK 1648925 T3 DK1648925 T3 DK 1648925T3
- Authority
- DK
- Denmark
- Prior art keywords
- imaging agents
- bicyclic peptide
- peptide imaging
- compounds
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Light Receiving Elements (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0317815.9A GB0317815D0 (en) | 2003-07-30 | 2003-07-30 | Imaging agents |
PCT/GB2004/003150 WO2005012335A1 (en) | 2003-07-30 | 2004-07-21 | Imaging agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1648925T3 true DK1648925T3 (da) | 2010-01-04 |
Family
ID=27799463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04743485T DK1648925T3 (da) | 2003-07-30 | 2004-07-21 | Bicyklisk peptid-billeddannende midler |
Country Status (24)
Country | Link |
---|---|
US (2) | US7410943B2 (da) |
EP (1) | EP1648925B1 (da) |
JP (1) | JP4625002B2 (da) |
KR (1) | KR101153529B1 (da) |
CN (1) | CN1829735B (da) |
AT (1) | ATE442379T1 (da) |
BR (1) | BRPI0412986A (da) |
CA (1) | CA2533321C (da) |
CY (1) | CY1109522T1 (da) |
DE (1) | DE602004023092D1 (da) |
DK (1) | DK1648925T3 (da) |
ES (1) | ES2332722T3 (da) |
GB (1) | GB0317815D0 (da) |
HK (1) | HK1097278A1 (da) |
HU (1) | HUP0600230A3 (da) |
IL (1) | IL173029A0 (da) |
MX (1) | MXPA06001090A (da) |
NO (1) | NO20060825L (da) |
NZ (1) | NZ544583A (da) |
PL (2) | PL210122B1 (da) |
PT (1) | PT1648925E (da) |
RU (2) | RU2355702C2 (da) |
SI (1) | SI1648925T1 (da) |
WO (1) | WO2005012335A1 (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002313616A1 (en) * | 2001-07-10 | 2003-01-29 | Amersham Health As | Peptide-based compounds for targeting intergin receptors |
GB0206750D0 (en) * | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
NO20033115D0 (no) * | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
US20060182692A1 (en) | 2003-12-16 | 2006-08-17 | Fishburn C S | Chemically modified small molecules |
NZ548529A (en) * | 2003-12-16 | 2010-08-27 | Nektar Therapeutics | Pegylated small molecules |
WO2005123767A1 (en) * | 2004-06-16 | 2005-12-29 | Ge Healthcare As | Peptide-based compounds |
GB0420344D0 (en) * | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
EP1814598B1 (en) | 2004-11-22 | 2011-01-12 | Ge Healthcare As | Contrast agents to target extracellular matrix |
US8986650B2 (en) | 2005-10-07 | 2015-03-24 | Guerbet | Complex folate-NOTA-Ga68 |
EP1940841B9 (fr) | 2005-10-07 | 2017-04-19 | Guerbet | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
EP2010227A2 (en) * | 2006-04-20 | 2009-01-07 | Hammersmith Imanet Limited | Radiofluorinated compounds and their preparation |
AU2007333846B2 (en) | 2006-12-14 | 2014-01-23 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
CA2939778C (en) | 2007-01-31 | 2019-01-29 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
ES2649941T3 (es) | 2007-02-23 | 2018-01-16 | Aileron Therapeutics, Inc. | Aminoácidos sustituidos para preparar péptidos macrocíclicos unidos a triazol |
KR101525754B1 (ko) | 2007-03-28 | 2015-06-09 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 스티칭된 폴리펩티드 |
GB0722650D0 (en) * | 2007-11-19 | 2007-12-27 | Ge Healthcare Ltd | Novel imaging method |
BRPI0906797A2 (pt) * | 2008-01-09 | 2015-07-14 | Molecular Insight Pharm Inc | Inibidores de anidrase carbônica ix |
JP5399422B2 (ja) * | 2008-02-28 | 2014-01-29 | ジーイー・ヘルスケア・リミテッド | 市販の安価な化学薬品からのpeg−6成分の合成 |
GB0814722D0 (en) * | 2008-08-12 | 2008-09-17 | Ge Healthcare Ltd | Treatment monitoring |
AU2009296235A1 (en) * | 2008-09-29 | 2010-04-01 | Gilead Sciences, Inc. | Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods |
BRPI1006139A2 (pt) | 2009-01-14 | 2017-05-30 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
GB0905438D0 (en) | 2009-03-30 | 2009-05-13 | Ge Healthcare Ltd | Radiolabelling reagents and methods |
GB0910013D0 (en) * | 2009-06-10 | 2009-07-22 | Ge Healthcare Ltd | PET imaging of fibogenesis |
JP2013505300A (ja) | 2009-09-22 | 2013-02-14 | エルロン・セラピューティクス・インコーポレイテッド | ペプチド模倣大環状分子 |
WO2011084763A1 (en) | 2009-12-21 | 2011-07-14 | Ge Healthcare Limited | Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion |
SI2603600T1 (sl) | 2010-08-13 | 2019-04-30 | Aileron Therapeutics, Inc. | Peptidomimetični makrocikli |
NZ609874A (en) | 2010-09-30 | 2014-10-31 | Astrazeneca Ab | Crystalline naloxol-peg conjugate |
FR2967671A1 (fr) * | 2010-11-24 | 2012-05-25 | Pf Medicament | Complexe de technetium 99m en tant qu'outil de diagnostic in vivo des tumeurs cancereuses |
KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
CN104159595A (zh) | 2012-02-15 | 2014-11-19 | 爱勒让治疗公司 | 拟肽大环化合物 |
WO2013123267A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
BR112015009470A2 (pt) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | aminoácidos dissubstituídos e seus métodos de preparação e uso |
WO2016049355A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and formulations thereof |
KR20170058424A (ko) | 2014-09-24 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
UY36351A (es) | 2014-10-14 | 2016-06-01 | Novartis Ag | Moléculas de anticuerpo que se unen a pd-l1 y usos de las mismas |
AU2016235424A1 (en) | 2015-03-20 | 2017-10-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
GB201511036D0 (en) | 2015-06-23 | 2015-08-05 | Guy S And St Thomas Hospital Nhs Foundation Trust | Imaging method |
US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP3347372A4 (en) | 2015-09-10 | 2019-09-04 | Aileron Therapeutics, Inc. | PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 |
GB201621864D0 (en) * | 2016-12-21 | 2017-02-01 | Ge Healthcare Ltd | Solid phase conditioning |
CN113000001A (zh) * | 2021-03-22 | 2021-06-22 | 洛阳海惠新材料股份有限公司 | 一种用于制备pbat的增粘连体反应器 |
CN113750923A (zh) * | 2021-08-30 | 2021-12-07 | 桐昆集团浙江恒腾差别化纤维有限公司 | 一种酯化反应回收系统 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992013572A1 (en) * | 1991-02-08 | 1992-08-20 | Diatech, Inc. | TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
EP1272507B1 (en) * | 2000-04-12 | 2005-06-29 | Amersham Health AS | Integrin binding peptide derivatives |
WO2002020610A2 (en) * | 2000-09-07 | 2002-03-14 | Biosynthema Inc. | Conformationally constrained labeled peptides for imaging and therapy |
IL141276A0 (en) * | 2001-02-05 | 2002-03-10 | Peptor Ltd | Backbone cyclized radiolabelled somatostatin analogs |
AU2002313616A1 (en) * | 2001-07-10 | 2003-01-29 | Amersham Health As | Peptide-based compounds for targeting intergin receptors |
-
2003
- 2003-07-30 GB GBGB0317815.9A patent/GB0317815D0/en not_active Ceased
-
2004
- 2004-07-21 ES ES04743485T patent/ES2332722T3/es active Active
- 2004-07-21 RU RU2006102324/04A patent/RU2355702C2/ru not_active IP Right Cessation
- 2004-07-21 MX MXPA06001090A patent/MXPA06001090A/es active IP Right Grant
- 2004-07-21 PT PT04743485T patent/PT1648925E/pt unknown
- 2004-07-21 JP JP2006521646A patent/JP4625002B2/ja not_active Expired - Fee Related
- 2004-07-21 EP EP04743485A patent/EP1648925B1/en not_active Not-in-force
- 2004-07-21 DE DE602004023092T patent/DE602004023092D1/de active Active
- 2004-07-21 CA CA2533321A patent/CA2533321C/en not_active Expired - Fee Related
- 2004-07-21 HU HU0600230A patent/HUP0600230A3/hu unknown
- 2004-07-21 DK DK04743485T patent/DK1648925T3/da active
- 2004-07-21 AT AT04743485T patent/ATE442379T1/de active
- 2004-07-21 SI SI200431293T patent/SI1648925T1/sl unknown
- 2004-07-21 US US10/566,487 patent/US7410943B2/en not_active Expired - Fee Related
- 2004-07-21 PL PL379705A patent/PL210122B1/pl not_active IP Right Cessation
- 2004-07-21 BR BRPI0412986-5A patent/BRPI0412986A/pt not_active IP Right Cessation
- 2004-07-21 WO PCT/GB2004/003150 patent/WO2005012335A1/en active Application Filing
- 2004-07-21 KR KR1020067001968A patent/KR101153529B1/ko not_active IP Right Cessation
- 2004-07-21 PL PL04743485T patent/PL1648925T3/pl unknown
- 2004-07-21 CN CN2004800220449A patent/CN1829735B/zh not_active Expired - Fee Related
- 2004-07-21 NZ NZ544583A patent/NZ544583A/xx not_active IP Right Cessation
-
2006
- 2006-01-09 IL IL173029A patent/IL173029A0/en unknown
- 2006-02-21 NO NO20060825A patent/NO20060825L/no not_active Application Discontinuation
-
2007
- 2007-03-01 HK HK07102321.9A patent/HK1097278A1/xx not_active IP Right Cessation
-
2008
- 2008-06-18 US US12/141,123 patent/US7811551B2/en not_active Expired - Fee Related
-
2009
- 2009-02-19 RU RU2009105640/04A patent/RU2009105640A/ru not_active Application Discontinuation
- 2009-12-01 CY CY20091101253T patent/CY1109522T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1648925T3 (da) | Bicyklisk peptid-billeddannende midler | |
NO20004795D0 (no) | Peptidbaserte forbindelser | |
MXPA04000173A (es) | Compuestos basados en peptidos. | |
ATE461196T1 (de) | Benzodiazepin-cgrp-rezeptor-antagonisten | |
EA200300441A1 (ru) | Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения | |
BRPI0411078A (pt) | ligantes de receptores de canabinóides e seus usos | |
ATE394400T1 (de) | Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
EA200301215A1 (ru) | Лиганды рецепторов 5-ht и их применение | |
EA200101177A1 (ru) | Производные индола в качестве антагонистов прогестерона | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
ATE509019T1 (de) | Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten | |
DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
DE60222396D1 (de) | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste | |
EP1605936A4 (en) | ARYL SPIROHYDANTINE CGRP RECEPTOR ANTAGONISTS | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
CY1110882T1 (el) | Ανταγωνιστες υποδοχεων ορεξινης υποκατεστημενης διαζεπανης | |
BR0008688A (pt) | Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18 | |
DE602006019304D1 (de) | Spirohydantoin-aryl-cgrp-rezeptorantagonisten | |
NO20024932D0 (no) | Kontrastmiddel | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
EA200501595A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
DE60217854D1 (de) | Herstellung von agonisten und antagonisten von cholecystokinin und ihre therapeutische und diagnostische verwendung | |
TR200103638T2 (tr) | IL-8 Reseptör antagonistleri | |
NO20033115D0 (no) | Peptid-baserte forbindelser |